뒤로
Acusphere Inc(ACUS) 가격
ACUS 주가 차트
ACUS 수입
Acusphere Inc
$0
0%
$0
종가: Jan 16, 16:00:00 GMT-5
$0
0%
$0
애프터마켓: Jan 16, 20:00:00 GMT-5
주요 통계
이전 종가
$0
시가
$0
일일 범위
$0 - $0
52주 범위
$0 - $0
거래량
125
평균 거래량
0
EPS(TTM)
-14.13
배당수익률
--
시가총액
$49.50000000000001
ACUS란 무엇인가요?
Acusphere, Inc. is a pharmaceutical company, which engages in the development of drugs and formulations of existing drugs using proprietary micro particle technology. The company is headquartered in Lexington, Massachusetts. The company went IPO on 2003-10-08. The firm is focused on the development of Imagify, which contains Perflubutane Polymer Microspheres for injectable suspension. The firm's product Imagify is a cardiovascular drug for the detection of coronary artery disease (CAD). Imagify injectable suspension consists of porous, synthetic polymer microspheres containing gas that are administered intravenously and act as tracers of blood flow or perfusion. The firm has submitted the Marketing Authorization Application (MAA) for its lead product candidate, Imagify lyophilisate for dispersion for injection with the European Medicines Agency (EMA) to support the regulatory review of Imagify in the European Union (EU).
